Chimera Capital Management Portfolio holdings
Top Buys
| 1 |
Crocs
CROX
|
+$30.3M |
| 2 |
Sally Beauty Holdings
SBH
|
+$16.7M |
| 3 |
Signet Jewelers
SIG
|
+$16.1M |
| 4 |
Medifast
MED
|
+$12.7M |
| 5 |
Dave & Buster's
PLAY
|
+$11M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$28M |
| 2 |
AutoZone
AZO
|
+$22.9M |
| 3 |
Williams-Sonoma
WSM
|
+$11.2M |
| 4 |
Macy's
M
|
+$9.24M |
| 5 |
HIBB
Hibbett, Inc. Common Stock
HIBB
|
+$8.48M |
Sector Composition
| 1 | Consumer Discretionary | 73.31% |
| 2 | Communication Services | 7.46% |
| 3 | Consumer Staples | 5.25% |
| 4 | Technology | 3.93% |
| 5 | Industrials | 3.65% |
Similar funds
Chimera Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Chimera Capital Management held 227 positions worth $360M, up 68% from $214M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Chimera Capital Management deployed $177M of net new capital in Q3 2022, opening 149 new positions and adding to 24 existing holdings. Its largest new stake was Sally Beauty Holdings: 1,204,628 shares worth $15.2M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 73% of assets, up from 72% a quarter earlier, followed by Communication Services and Consumer Staples.
On the sell side, the largest reduction was Ulta Beauty, an estimated $3.42M trimmed.
- Chimera Capital Management's largest Q3 2022 buy was Sally Beauty Holdings: 1,204,628 shares worth $15.2M.
- Chimera Capital Management added most to Crocs in Q3 2022, an estimated $30.3M increase.
- Chimera Capital Management's biggest Q3 2022 reduction was Ulta Beauty, cutting an estimated $3.42M.
- Chimera Capital Management fully exited Invesco QQQ Trust in Q3 2022, selling an estimated $28M.
- Chimera Capital Management's ten largest holdings make up 40% of its $360M portfolio in Q3 2022.
- Chimera Capital Management opened 149 new positions and closed 48 in Q3 2022.
- Chimera Capital Management's portfolio value rose 68% quarter-over-quarter to $360M.
Based on Chimera Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.